Cancer

INDICATION: Acute myelogenous leukemia (AML); prostate cancer

In vitro, cell culture and mouse studies identified two dihydropyrazolopyridine-based dual CREBBP/EP300 inhibitors that could help

Read the full 229 word article

User Sign In